Target intelligence / Profile preview

Ribosomal protein SA pseudogene 35 (RPSAP35)

Target
RPSAP35
Molecular classification
Other, Pseudogene
01

Overview

Ribosomal protein SA pseudogene 35 (RPSAP35) is annotated as a pseudogene related to the RPSA gene, which encodes ribosomal protein SA—a protein that functions as both a component of the ribosomal small subunit and a high-affinity laminin receptor at the cell surface. Pseudogenes such as RPSAP35 do not produce functional proteins and are generally considered to be non-coding genomic sequences derived from retrotransposition or duplication events involving protein-coding genes. Unlike functional ribosomal proteins or receptors, RPSAP35 does not participate in canonical protein synthesis, cell signaling, or serve as a receptor, and there is no documented evidence that it plays a role in disease, drug response, or as a biomarker. Essential context: Ribosomal protein SA (RPSA) is a multifunctional protein involved in both ribosomal function and extracellular matrix signaling, implicated in cancer progression and laminin binding. However, RPSAP35 is a pseudogene and does not share these roles. Pseudogenes are typically excluded from lists of bona fide drug targets, and there is no evidence or database entry suggesting that RPSAP35 has any therapeutic relevance.

Other names
RPSAP35RPSA_13_513Ribosomal protein SA pseudogene 35
02

Biological functions

None (pseudogenes, by definition, usually lack direct biological functions as they do not produce functional proteins)
03

Disease associations

None (no direct disease association; the parent gene RPSA has been implicated in cancer progression and metastasis, but pseudogenes like RPSAP35 have no established role)

Beyond the preview

Go deeper on Ribosomal protein SA pseudogene 35 (RPSAP35).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein SA pseudogene 35 (RPSAP35).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call